Unrated UCB to market bond after two year absence

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Unrated UCB to market bond after two year absence

biopharma

UCB, the unrated Belgian pharmaceuticals company, is sounding out demand for a senior unsecured euro bond for general financing purposes among European investors.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article